Special Issue "Lung Cancer"

Quicklinks

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (30 December 2010)

Special Issue Editor

Guest Editor
Prof. Dr. Gerolama Condorelli
Department of Cellular and Molecular Biology and Pathology, Istituto di Endocrinologia e Oncologia Sperimentale ‘‘G. Salvatore’’-Consiglio Nazionale delle Ricerche, Faculty of Biotechnological Science, ‘‘Federico II’’ University of Naples, I-80121 Naples, Italy
Website: https://www.docenti.unina.it/cercaDocente.do?cognome=condorelli&submit1=avvia+ricerca
E-Mail: gecondor@unina.it
Interests: apoptosis; cell death; TRAIL; microRNA; cell motility; chemotherapy resistance

Special Issue Information

Dear Colleagues,

Lung cancer is the leading cause of cancer death in both men and women worldwide. It is becoming apparent, through candidate gene and genome-wide approaches, that clinically evident lung cancers accumulate numerous clonal genetic and epigenetic alterations during a multistep process. These alterations include tumor suppressor gene inactivation and activation of growth or survival promoting oncogenes.

Despite advances in early detection and standard treatment, lung cancer is often diagnosed at an advanced stage and have poor prognoses. The development of innovative, targeted therapies may represent an alternative for the treatment of these cancers.

One of the most important factors that affect survival rate is resistance to therapeutic drugs. Thus development of effective therapeutic approaches is necessary for the management of these common cancers. MiRNAs are attractive drug targets since they regulate expression of many cellular proteins and are differentially
MicroRNAs are small noncoding RNAs that show expression loss or gain in most cancers, and there is growing evidence that they play substantial roles in the pathogenesis and prognosis of human malignancies.

The central focus of the special issue on “Lung Cancer” is identification of molecular pathways involved in lung tumorigenesis and therapeutic resistance. The main topics will include, but are not limited to, the role of cell death (e.g., apoptosis and necrosis) and cell survival pathways (e.g., autophagy) in tumorigenesis and chemotherapy resistance; role microRNAs and their targets in lung prognosis, diagnosis and response to therapy.
Thank you for your collaboration.

Prof. Dr. Gerolama Condorelli
Guest Editor

Keywords

  • lung cancer
  • MicroRNAs
  • apoptosis
  • autophagy
  • caspases
  • cell death
  • cell survival
  • death receptors
  • oncogenes
  • tumor suppressor genes

Published Papers (11 papers)

Cancers 2011, 3(4), 4258-4268; doi:10.3390/cancers3044258
Received: 13 October 2011; in revised form: 29 November 2011 / Accepted: 6 December 2011 / Published: 14 December 2011
Show/Hide Abstract | Download PDF Full-text (101 KB) | View HTML Full-text | Download XML Full-text

Cancers 2011, 3(3), 2975-2989; doi:10.3390/cancers3032975
Received: 3 June 2011; in revised form: 11 July 2011 / Accepted: 12 July 2011 / Published: 19 July 2011
Show/Hide Abstract | Download PDF Full-text (250 KB) | View HTML Full-text | Download XML Full-text

Cancers 2011, 3(2), 2667-2678; doi:10.3390/cancers3022667
Received: 28 April 2011; in revised form: 1 June 2011 / Accepted: 7 June 2011 / Published: 10 June 2011
Show/Hide Abstract | Download PDF Full-text (198 KB) | View HTML Full-text | Download XML Full-text

Cancers 2011, 3(2), 2333-2357; doi:10.3390/cancers3022333
Received: 7 March 2011; in revised form: 28 April 2011 / Accepted: 3 May 2011 / Published: 11 May 2011
Show/Hide Abstract | Download PDF Full-text (286 KB) | View HTML Full-text | Download XML Full-text

Cancers 2011, 3(2), 1861-1876; doi:10.3390/cancers3021861
Received: 4 January 2011; in revised form: 18 March 2011 / Accepted: 31 March 2011 / Published: 1 April 2011
Show/Hide Abstract | Download PDF Full-text (188 KB) | View HTML Full-text | Download XML Full-text

Cancers 2011, 3(1), 1426-1453; doi:10.3390/cancers3011426
Received: 29 December 2010; in revised form: 9 March 2011 / Accepted: 10 March 2011 / Published: 17 March 2011
Show/Hide Abstract | Download PDF Full-text (308 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Cancers 2011, 3(1), 1195-1231; doi:10.3390/cancers3011195
Received: 7 January 2011; in revised form: 28 February 2011 / Accepted: 1 March 2011 / Published: 10 March 2011
Show/Hide Abstract | Download PDF Full-text (871 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Cancers 2011, 3(1), 1014-1041; doi:10.3390/cancers3011014
Received: 31 December 2010; in revised form: 20 February 2011 / Accepted: 1 March 2011 / Published: 3 March 2011
Show/Hide Abstract | Download PDF Full-text (373 KB) | View HTML Full-text | Download XML Full-text

Cancers 2011, 3(1), 789-801; doi:10.3390/cancers3010789
Received: 30 December 2010; in revised form: 9 February 2011 / Accepted: 15 February 2011 / Published: 23 February 2011
Show/Hide Abstract | Download PDF Full-text (420 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Cancers 2010, 2(4), 2153-2170; doi:10.3390/cancers2042153
Received: 20 October 2010; in revised form: 25 November 2010 / Accepted: 21 December 2010 / Published: 22 December 2010
Show/Hide Abstract | Download PDF Full-text (1363 KB) | View HTML Full-text | Download XML Full-text |  Correction
abstract graphic

Cancers 2010, 2(4), 1813-1829; doi:10.3390/cancers2041813
Received: 15 September 2010; in revised form: 15 October 2010 / Accepted: 24 October 2010 / Published: 28 October 2010
Show/Hide Abstract | Download PDF Full-text (238 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Last update: 25 February 2014

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert